At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy—Are We Closer to Effective Treatment for Patients?

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms19051490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Hodgkin Lymphoma Classification: Are We at a Crossroads?

Cancer
Cancer ResearchOncology
2017English

Steroids in Duchenne Muscular Dystrophy: From Clinical Trials to Genomic Research

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2002English

Comparative Proteomic Analyses of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Muscles: Changes Contributing to Preserve Muscle Function in Becker Muscular Dystrophy Patients

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2020English

Human Immunoglobulin G for Experimental Treatment of Duchenne Muscular Dystrophy

Clinical and Experimental Immunology
AllergyImmunology
2014English

The Concept of Risk in Finance and Strategy: Are We Arriving at the Crossroads?

Journal of Hospitality Financial Management
ManagementHospitality ManagementLeisureStrategyTourismFinance
2004English

Chiropractic at the Crossroads or Are We Just Going Around in Circles?

Chiropractic and Manual Therapies
ComplementaryPhysical TherapyAlternative MedicineSports TherapyRehabilitationChiropractics
2011English

OC10.05: How Effective Are We at Detecting Small-For-Gestational-Age Infants?

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

RNAseq Analysis for the Diagnosis of Muscular Dystrophy

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2015English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy